🚀 Elevate your research, impact patient care: Join the JUMPstart #ClinicalNutrition Program 2024/25 – with in-depth learning about #CriticalCare nutrition, expert mentorship & the chance to receive a €250,000 research grant. Apply by July 31!
👉 More on nutritionevents.com/networks/jumps…

Back at ESPGHAN, Milan! Explore medical nutrition solutions for advanced patient care. Showcasing products for healthcare professionals, parenteral nutrition in neonate growth and omega-3 benefits 📑 Join our Symposium #ESPGHAN2024

👩‍🔬 👨🏾‍⚕️ Calling all research talents with a focus on #Nephrology and #RenalNutrition in #CKD pre-dialysis: Elevate your research with the JUMPstart Renal Nutrition Therapy Program - and the chance to receive our €100,000 research grant.
👉 Learn more: ckd-diet.com/jumpstart

We proceed on our #Biopharma pathway in line with #Vision2026 : mAbxience and Teva Pharmaceuticals International have entered a licensing agreement for a biosimilar currently in development for #Oncology indications.
#FutureFresenius

Explore how to improve nutrition care of critically ill patients with #dysphagia , a frequently underrecognized problem in the intensive care unit.
👉 Watch the full video with Dr. Jackie McRae SLTsinCC on nutritionevents.com.
#NutritionSupport #ICU

Bonjour from Bordeaux! 🙌
Thank you to everyone who has already visited our team at the Fresenius Kabi booth at #EAHP 2024 congress.

If you have not been there yet, our team is looking forward to your visit! 🚀

#EAHP #HospitalPharmacy #FreseniusKabi
@EAHPtweet

🔬 If you want to apply for the ESICM - Fresenius Kabi Clinical Nutrition Award, you now have 18 more days to prepare your application!
👉New deadline: 4 April, 23:59h CEST

Join us for #EAHP2024 ! Discover our KabiPac products, our ready-to-use IV and Oncology portfolio and #Biosimilars for the treatment of inflammatory and immune diseases. Don’t miss our live demo of solutions for simplified preparation of parenteral nutrition. See you in Bordeaux👋

🌟 Celebrating #InternationalWomensDay ! At Fresenius Kabi, we're committed to empowering women through tailored training programs and fostering an inclusive culture. Get first-hand insights from some of the participants here: fresenius-kabi.com/inspiring-stor…
#InspireInclusion

Great news: The FDA has approved our tocilizumab #biosimilar , making it the first tocilizumab biosimilar to receive approval for both IV and subcutaneous formulations in the U.S.

#FutureFresenius #Fresenius #Fresenius Kabi

Are you dreaming of making a real impact in nutrition science? Apply now for the ESICM - Fresenius Kabi Clinical Nutrition Award and grab the opportunity to win a grant of €20,000 for your #NutritionResearch project: esicm.org/research/award…
Applications are open until March 17.

The synergy between research and education is crucial as it drives innovation and #AdvancingPatientCare . ⚡ To further foster research and medical training in #IntensiveCare , Fresenius Kabi continues its collaboration with the ESICM in 2024. Learn more: fresenius-kabi.com/news/fresenius…

We just published our full year results for 2023 in advance of the press conference. Fresenius closed FY/23 with a strong fourth quarter driven by the performance of Fresenius Kabi and Fresenius Helios, and Vamed's ongoing improvements. 📈
fresenius.com/node/6788

On #WomenAndGirlsInScience Day, we celebrate the incredible impact of women in #AdvancingPatientCare . Delve into inspiring interviews with five remarkable colleagues, exploring their motivations and triumphs in science: fresenius-kabi.com/inspiring-stor… 🌟🔬